KO Volume Alert - KO 42.32 Coca-Cola Company $KO Hit a high

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
KO Volume Alert - KO 42.32 Coca-Cola Company $KO Hit a high of 42.46 Currently 11/07/14 Last price 42.32 +0.03 +0.07% With a day low of 42.14 and a current volume of 11,792,899.

KO Coca-Cola Company Recent Headline News

7 Best Business Books Coming Out This Week: TheStreet's Picks
at The Street - Sat Nov 08, 8:40AM CST
'Twitter is Not a Strategy,' the hot new business book by Tom Doctoroff, headlines our list of the best new business books to look out for this week.
KO: 42.32 (+0.03), NKE: 93.78 (-0.82), FB: 75.60 (+0.34), GOOGL: 551.82 (+0.13), TWTR: 40.31 (-0.53), AAPL: 109.01 (+0.31)

3 Steps to a Great Stock Portfolio
Matthew Frankel, The Motley Fool - Motley Fool - Sat Nov 08, 7:49AM CST
If you're one of the millions of investors who love picking their own stocks, it can be tough to decide which companies are best for your portfolio. Source: 401kcalculator.org via flickr However, if you follow a few simple guidelines, it...
KO: 42.32 (+0.03), AXP: 92.26 (+0.68), PG: 89.13 (+0.23)

'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock?
at The Street - Sat Nov 08, 4:00AM CST
The trading panel discussed whether it would help or hurt Twitter if its CEO steps down and whether Coca-Cola has any fizz left in it.
KO: 42.32 (+0.03), YHOO: 48.55 (+0.62), MNST: 108.39 (+7.91), ANF: 29.50 (-5.88), SLXP: 91.47 (-47.08), FFIV: 126.66 (+1.45), AKS: 6.62 (+0.48), TWTR: 40.31 (-0.53), GDX: 18.64 (+1.43), FXF: 101.10 (+0.79)


Berkshire's earnings down 9 percent from year ago
By JOSH FUNK - AP - Fri Nov 07, 5:53PM CST
OMAHA, Neb. (AP) — Warren Buffett's Berkshire Hathaway reported a 9 percent drop in third-quarter profit versus the same period a year ago, when the company had large investment gains.
KO: 42.32 (+0.03), WFC: 53.84 (-0.22), BRK.B: 143.61 (+0.32), BRK.A: 214,970.00 (+170.00)

Warren Buffett's Berkshire Hathaway Beats 3Q Earnings Estimates
at The Street - Fri Nov 07, 5:27PM CST
Warren Buffett's Berkshire Hathaway posted third-quarter financial results after the bell on Friday, exceeding analyst estimates.
KO: 42.32 (+0.03), IBM: 162.07 (+0.61), BRK.B: 143.61 (+0.32), BRK.A: 214,970.00 (+170.00)

Final Glance: Beverages companies
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — Shares of some top beverages companies were mixed at the close of trading:
KO: 42.32 (+0.03), BUD: 108.34 (-0.16), TAP.A: 80.50 (+0.38), TAP: 77.18 (+0.13)

Monster Beverage Jumps, Analyst Sees Coke Boost Ahead
at Investor's Business Daily - Fri Nov 07, 1:44PM CST
Monster Beverage (MNST) is primed to see accelerating growth in its fourth quarter and into next year as the energy-drink hotshot benefits from a partnership with Coca-Cola Co. (KO) that should boost its overseas business, according to a report from...
KO: 42.32 (+0.03), FIZZ: 24.55 (-1.22), MNST: 108.39 (+7.91)

3 Warren Buffett Secrets for a Prosperous Retirement
Adam Galas, The Motley Fool - Motley Fool - Fri Nov 07, 1:07PM CST
Many Americans are worried about their ability to sustain their lifestyle during retirement, and it's no wonder. According to the recent survey from Wells Fargo , a large portion of the country is ill prepared to fund its golden years:  "Nearly a...
KO: 42.32 (+0.03), AXP: 92.26 (+0.68), IBM: 162.07 (+0.61), WMT: 78.77 (+0.96), WFC: 53.84 (-0.22)

Midday Glance: Beverages companies
AP - Fri Nov 07, 12:18PM CST
NEW YORK (AP) — Shares of some top beverages companies are mixed at 1 p.m.:
KO: 42.32 (+0.03), BUD: 108.34 (-0.16), TAP.A: 80.50 (+0.38), TAP: 77.18 (+0.13)

Monster Beverage (MNST) Beats on Q3 Earnings, Lags Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 11:23AM CST
Monster Beverage Corporation's (MNST) third-quarter 2014 adjusted earnings of 70 cents per share beat the Zacks Consensus Estimate by 2.9%.
KO: 42.32 (+0.03), MNST: 108.39 (+7.91)

Cramer: Coca-Cola Needs to Buy Monster Beverage, Keurig Green Mountain
at The Street - Fri Nov 07, 10:36AM CST
Cramer said Coca-Cola needs Monster Beverage and Keurig Green Mountain if it wants to grow and make shareholders happy.
KO: 42.32 (+0.03), MNST: 108.39 (+7.91), GMCR: 152.90 (-0.16)

Early Glance: Beverages companies
AP - Fri Nov 07, 9:53AM CST
NEW YORK (AP) — Shares of some top beverages companies are mixed at 10 a.m.:
KO: 42.32 (+0.03), BUD: 108.34 (-0.16), TAP.A: 80.50 (+0.38), TAP: 77.18 (+0.13)

Monster Beverage Corp Earnings Show a Strong Leader in a Maturing Market
Alex Planes, The Motley Fool - Motley Fool - Fri Nov 07, 9:20AM CST
Energy-drink leader Monster Beverage offered somewhat mixed results in its third-quarter earnings report after Thursday's closing bell. Analysts had expected $641.8 million in net revenue and $0.67 in earnings per share. Monster narrowly missed on...
KO: 42.32 (+0.03), MNST: 108.39 (+7.91)

Can SodaStream Get Its Pop Back?
Jeremy Bowman, The Motley Fool - Motley Fool - Fri Nov 07, 9:15AM CST
The verdict may be in on SodaStream International , the highly shorted growth stock that peaked near $80 before crashing all the way down to $20 this year. Macy's recently announced it would stop carrying the brand in response to weak sales, a...
KO: 42.32 (+0.03), M: 59.88 (+0.84), SODA: 22.00 (-0.46), PEP: 96.80 (-0.01)

Coca-Cola Rolls Out Coca Cola Life Drink Nationwide - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 4:20PM CST
The Coca-Cola Company recently announced a nationwide launch of Coca-Cola Life, a naturally sweetened reduced-calorie cola.
DPS: 69.95 (+0.01), KO: 42.32 (+0.03), MNST: 108.39 (+7.91), PEP: 96.80 (-0.01)

Berkeley's Soda Tax Deals a Painful Blow to Coca-Cola
Jamal Carnette, The Motley Fool - Motley Fool - Thu Nov 06, 2:30PM CST
Coca-Cola Life may be the company's most important beverage going forward. Source: The Coca-Cola Company. On Election Day, voters in California took to the polls to make their voice heard on the political process ... and soda. That's right: Voters...
KO: 42.32 (+0.03), MNST: 108.39 (+7.91)

First Ever Client Appointed as Creative Effectiveness Lions Jury President
JCN Newswire - Thu Nov 06, 12:47PM CST
Coinciding with the opening of entries to the Creative Effectiveness Lions, Cannes Lions has today announced the appointment of Wendy Clark, President of Sparkling Brands & Strategic Marketing, Coca-Cola North America as Jury President.
KO: 42.32 (+0.03)

Most active New York Stock Exchange-traded stocks
AP - Thu Nov 06, 12:17PM CST
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:
KO: 42.32 (+0.03), F: 14.17 (-0.02), GE: 26.41 (+0.05), RF: 10.16 (-0.07), ABX.TO: 13.79 (+0.82), K.TO: 2.84 (+0.30), ABX: 12.16 (+0.82), AKS: 6.62 (+0.48), BAC: 17.36 (unch), ANR: 2.91 (+0.39), GNW: 8.41 (-0.25), YRI.TO: 4.47 (+0.44), S: 4.72 (+0.03), KGC: 2.50 (+0.29), TWTR: 40.31 (-0.53), AUY: 3.92 (+0.38), AM: 28.07 (-0.18)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles